The Recall Desk
ModerateFDA (Devices)·Z-0641-2023·Announced 2022-12-21

DeRoyal NEURO PACK medical device recalled voluntarily by manufacturer

DeRoyal Industries Inc initiated a voluntary recall of 93 kits of the DeRoyal NEURO PACK affecting 23 U.S. states. The recall affects three lot numbers with March 1, 2025 expiration.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is a voluntary, firm-initiated Class II medical device recall without reported illnesses or injuries. Per the severity rubric, voluntary precautionary recalls are classified as Moderate (Score 2).

Plain-English summary

DeRoyal Industries Inc initiated a voluntary recall of the DeRoyal NEURO PACK (REF 89-9253.07) affecting 93 kits. The recalled product was distributed to medical facilities and providers in 23 states: Tennessee, Texas, New York, Wisconsin, Florida, Virginia, Massachusetts, Arizona, Missouri, Connecticut, New Jersey, Pennsylvania, North Carolina, Louisiana, Michigan, Minnesota, Ohio, Indiana, Kansas, Illinois, Alabama, Georgia, and Mississippi.

The recall affects the following lot numbers, all expiring March 1, 2025: Lot 56389334, Lot 56615629, and Lot 57003940. The firm initiated the recall on November 3, 2022, and the FDA classified it as a Class II recall on December 15, 2022.

The recall was initiated voluntarily by the manufacturer. Individuals in possession of affected product should contact DeRoyal Industries Inc at its Powell, Tennessee facility for guidance on next steps.

The recalled product

Product
DeRoyal NEURO PACK, REF 89-9253.07
Manufacturer
DeRoyal Industries Inc

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot Numbers: Lot 56389334 exp 3/1/2025
  • Lot 56615629 exp 3/1/2025
  • Lot 57003940 exp 3/1/2025

Distribution

Distribution scope not specified by the agency.